Document Detail


Intracavitary amphotereicin B in the treatment of symptomatic pulmonary aspergillomas.
MedLine Citation:
PMID:  7361807     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The optimal treatment of pulmonary aspergillomas is not established. Surgical resection is often impossible because of severe, underlying pulmonary impairment, and medical treatment has given negative or inconclusive results. Six patients with symptomatic pulmonary aspergillomas were treated with percutaneous instillation of intracavitary amphotericin B. Four patients who received the full course of therapy showed improvement and stabilization or reversal of progressive roentgenographic changes. Also, follow-up serologic studies of Aspergillus spp. precipitins were obtained in three and were negative. One patient did not tolerate this treatment because of repeated systemic reactions. Another patient did not respond clinically or roentgenographically. Intracavitary amphotericin B therapy should be considered in patients with symptomatic pulmonary aspergilloma, particularly when surgical resection is not feasible.
Authors:
J L Hargis; R C Bone; J Stewart; N Rector; F C Hiller
Related Documents :
21307117 - Semi-customizing patient surveys: linking results and organizational conditions.
18842917 - Acute exacerbations of fibrotic hypersensitivity pneumonitis: a case series.
17997087 - Clinical significance of mycobacterium fortuitum isolated from respiratory specimens.
21237167 - An alerting system improves adherence to follow-up recommendations from colonoscopy exa...
21900187 - Feasibility of a heart failure disease management program in eastern europe: tbilisi, g...
2901407 - Treatment of anxiety associated with electrophysiologic studies.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The American journal of medicine     Volume:  68     ISSN:  0002-9343     ISO Abbreviation:  Am. J. Med.     Publication Date:  1980 Mar 
Date Detail:
Created Date:  1980-05-23     Completed Date:  1980-05-23     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0267200     Medline TA:  Am J Med     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  389-94     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Amphotericin B / administration & dosage*,  adverse effects
Aspergillosis, Allergic Bronchopulmonary / drug therapy*,  radiography,  surgery
Female
Humans
Injections
Male
Middle Aged
Chemical
Reg. No./Substance:
1397-89-3/Amphotericin B

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Arthralgia associated with acute urinary retention. A syndrome of probable viral etiology.
Next Document:  High uric acid as an indicator of cardiovascular disease. Independence from obesity.